Professor Paterson said the aim was to treat COVID-19 patients as soon as they were admitted to hospital.
Professor David Paterson, director of the University of Queensland Centre for Clinical Research, told news.com.au that his lab is looking to trial two existing drugs to treat patients with COVID-19. For example, in one case, one of the medications was given to some of the first people tested positive for COVID-19 and resulted in a complete recovery. Professor David Paterson is Director at The University of Queensland Centre for Clinical Research. I’m Professor David Paterson, Royal Brisbane and Women’s Hospital (RBWH) Consultant Infectious Diseases Physician. UQ Professor David Paterson said patients would be placed randomly in one of four treatment groups. He is also a consultant infectious diseases physician at the Royal Brisbane and Women's Hospital. “A third group is being given a combination of the two drugs, and a fourth group will receive standard care.” “One group of patients is being given the HIV drug, while another will be administered the malaria drug,” Professor Paterson said. Australian researchers are set to begin clinical trials of a potential treatment for COVID-19 – using two existing drugs.. University of Queensland Centre for Clinical Research Director and Consultant Infectious Diseases Physician at the Royal Brisbane and Women’s Hospital (RBWH) Professor David Paterson said the drugs proved highly effective when first used against the virus in test tubes. I oversee a team of world-leading clinical researchers and scientists who are working on a broad range of projects that will help in the fight against COVID-19. Professor Paterson at the University of Queensland Centre for Clinical Research reports that there is some evidence supporting these candidates.